Gujarat Themis Biosyn Share price

Q: How to buy Gujarat Themis Biosyn Share at Choice?

To buy Gujarat Themis Biosyn stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Themis Biosyn, choose your preferred order type, and place the trade.

GUJTHEM

Healthcare Mid Cap

370.3

2.70 (-0.72%)

NSE

BSE

Last updated on 15 May, 2026 | 15:31 IST

BUYSELL

Today's High

380.00

Today's Low

365.35

52 Week Low

225.05

52 Week High

479.00

Free Demat with Zero AMC*

Gujarat Themis Biosyn Chart

ChartIQ

TradingView

Gujarat Themis Biosyn Share Key Metrics

Volume

27988.00

Market Cap

4034.98 CR

LTQ@LTP

250@370.30

ATP

374.73 Var Margin

25.53 %

Circuit Range

298.4-447.6

Delivery %

39.89 %

Value

1.05 CR

ASM/GSM

No

Market Lot

1

Summary

Gujarat Themis Biosyn share price is ₹370.3 as of 16 May, 2026. The stock Gujarat Themis Biosyn intraday movement has stayed between ₹365.35 and ₹380.00, while on a 52-week basis,Gujarat Themis Biosyn price 52 week high is ₹479.00 & its 52 week low is ₹225.05.

In terms of trading activity, Gujarat Themis Biosyn has recorded a volume of 27988 shares, The Gujarat Themis Biosyn has a market cap of ₹108965265 CR. The stock’s Average Traded Price (ATP) stands at ₹374.73, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 250 @ ₹370.30.

Gujarat Themis Biosyn operates within a circuit range of ₹298.40 – ₹447.60, with a Value of ₹1.05 CR. The Delivery Percentage for the day is 39.89%. Additionally, Gujarat Themis Biosyn currently falls under the No framework, and trades with a market lot size of 1.

Gujarat Themis Biosyn Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Gujarat Themis Biosyn Resistance and Support

Pivot 374.92

Resistance

First Resistance

380.54

Second Resistance

388.07

Third Resistance

393.69

Support

First Support

367.39

Second Support

361.77

Third Support

354.24

Gujarat Themis Biosyn Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.86%

Mutual Fund

1.16%

Insurance

0%

Foreign Institutional Investors

1.96%

Domestic Institutional Investors

0.01%

Retail

26%

Others

0.01%

Total Promoters

MAR '25

70.86%

JUN '25

70.86%

SEP '25

70.86%

DEC '25

70.86%

Gujarat Themis Biosyn Corporate Actions

Date	Agenda
2026-02-05	Quarterly Results
2025-11-10	Quarterly Results
2025-08-01	Quarterly Results
2025-05-20	Audited Results & Final Dividend
2025-02-14	Quarterly Results

Gujarat Themis Biosyn News

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn announced a postal ballot to seek shareholder approval for two special resolutions. These include increasing the company's borrowing limits and enhancing inter-corporate loan and investment limits.

May 06 2026 12:05:00

Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Gujarat Themis Biosyn Ltd initiated a postal ballot to secure shareholder approval for enhancing its borrowing capabilities under Section 180(1)(c) and increasing investment/loan limits under Section 186. This move provides the company with greater financial flexibility for future growth.

May 06 2026 12:05:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn will conduct a postal ballot to obtain shareholder approval for two special resolutions. These resolutions aim to increase the company's borrowing limits and enhance the limits for providing inter-corporate loans, guarantees, and making investments.

May 05 2026 21:05:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn will conduct a postal ballot to obtain shareholder approval for two special resolutions. These resolutions aim to increase the company's borrowing limits and enhance the limits for providing inter-corporate loans, guarantees, and making investments.

May 05 2026 21:05:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn seeks shareholder approval via postal ballot to increase borrowing limits and authorize loans/investments, each up to Rs. 3,500 crores. These actions are crucial for funding growth, capacity expansion, strategic investments, and a planned acquisition from Sanofi.

May 05 2026 21:05:00

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Gujarat Themis Biosyn seeks shareholder approval to raise borrowing limits to ₹3,500 crores and inter-corporate loan/investment limits to ₹3,500 crores. These measures are crucial for funding business expansion and the acquisition of Sanofi's anti-tuberculosis and anti-infective brands.

May 05 2026 21:05:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn acquired 13 branded generic products from Sanofi for Euro 158 million (₹1,740 crores). This strategic acquisition aims to strengthen its global pharmaceutical platform and expand its presence in the anti-infective segment across over 55 countries.

Apr 24 2026 00:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn acquired 13 branded generic products from Sanofi for Euro 158 million (₹1,740 crores). This strategic acquisition aims to strengthen its global pharmaceutical platform and expand its presence in the anti-infective segment across over 55 countries.

Apr 23 2026 23:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited acquired Sanofi's global Anti-TB and Anti-Infective Portfolio for approximately €158 million. The acquired portfolio boasts €62 million in FY25 revenue, 13 established brands, and a presence in 55+ countries, structured as an asset acquisition.

Apr 23 2026 23:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Ltd (GTBL) is acquiring Sanofi's Global Anti-TB and Anti-Infective Portfolio for EUR 158 million, a strategic move to strengthen its global pharmaceuticals platform and expand into regulated markets. This acquisition, expected to close by Q3FY27, is poised to enhance GTBL's international presence.

Apr 23 2026 23:04:00

NSE : 29731

BSE : 506879

ISIN : INE942C01045

Gujarat Themis Biosyn Management

Name	Position
Vineet G Gawankar	Company Secretary & Compliance Officer
Dinesh S Patel	Chairman

Gujarat Themis Biosyn Similar Stocks

RPG Life Sciences Ltd.

2292.50

-55.90 (2.38%)

SMS Pharmaceuticals Ltd.

400.40

0.90 (0.23%)

Indraprastha Medical Corporation Ltd.

367.75

-10.80 (2.85%)

Orchid Pharma Ltd.

712.60

-6.65 (0.92%)

Aarti Drugs Ltd.

367.75

5.40 (1.49%)

IOL Chemicals And Pharmaceuticals Ltd.

105.94

-3.41 (3.12%)

Bliss GVS Pharma Ltd.

277.65

-11.75 (4.06%)

Gufic Biosciences Ltd.

282.00

-4.50 (1.57%)

Dishman Carbogen Amcis Ltd.

194.25

16.62 (9.36%)

Unichem Laboratories Ltd.

372.40

8.45 (2.32%)

Gujarat Themis Biosyn FAQs

The Buying Price of Gujarat Themis Biosyn share is 370.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Gujarat Themis Biosyn stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Themis Biosyn, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Gujarat Themis Biosyn shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Gujarat Themis Biosyn shares is 0. Useful to assess the stock's value relative to its book value.

To assess Gujarat Themis Biosyn’s valuation compare Sector P/E, P/B which are 71.32 & 3.47 with sector averages, along with growth rates and financial metrics.

The Market Cap of Gujarat Themis Biosyn is 4034.98 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Gujarat Themis Biosyn share price is 479.00 & 225.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Gujarat Themis Biosyn belongs to the Healthcare sector.